Chairman of the Board at Proteon Therapeutics, Inc.
Mr. Hastings has served as a director since June 2011 and as our Lead Director since June 2013. Mr. Hastings has served as President and Chief Executive Officer of Nkarta Therapeutics, Inc, since February 2018. Prior to that, Mr. Hastings served as the President and Chief Executive Officer and a member of the board of directors of OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED), a clinical development-stage biopharmaceutical company, from January 2006 until January 2018. In August 2013, he was elected chairman of the board. Prior to joining OncoMed, Mr. Hastings was President and Chief Executive Officer of QLT, Inc., a biotechnology company focu ...
Source: Pacira Pharmaceuticals, Inc. on 04/27/2017
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Paul J. Hastings. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: Paul J. Hastings
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.